Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of the Touro College & University System, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to Scholarly Communications Librarian Carrie Levinson.

Total number of publications: 7,260

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 282 283 284 285 286 287 288 289 290 291 Next Last
  • Zheng, X., Zhuge, J., Bezerra, S. M., Faraj, S. F., Fallon, J. T., . . . Zhong, M. (2014). High frequency of TERT promoter mutations in small cell carcinoma of the urinary bladder, but not in small cell carcinoma of lung. Laboratory Investigation, 94(Suppl. 1), 272A.

  • Zheng, X., Zhuge, J., Bezerra, S. M., Faraj, S. F., Munari, E., Fallon, J. T., . . . Zhong, M. (2014). High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. Journal of Hematology & Oncology, 7, 47. doi:10.1186/s13045-014-0047-7

  • Zhong, M., Joseph, T. W., Jackson, D., Beychenok, S., & Foster, D. A. (2002). Elevated phospholipase D activity induces apoptosis in normal rat fibroblasts. Biochemical and Biophysical Research Communications, 298(4), 474-477. doi:10.1016/S0006-291X(02)02495-6

  • Zhong, M., Mankovich, A., Zhuge, J., Huang, W., Wang, G., Dimitrova, N., . . . Fallon, J. T. (2016). Validation of an amplicon-based NGS cancer panel and informatics pipeline as potential replacement for sanger and PCR-based methods for somatic mutation detection in a hospital clinical laboratory. Journal of Molecular Diagnostics, 18(6), 1005.

  • Zhong, M., Shen, Y., Zheng, Y., Joseph, T. W., Jackson, D., & Foster, D. A. (2003). Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochemical and Biophysical Research Communications, 302(3), 615–619. doi:10.1016/S0006-291X(03)00229-8

  • Zhong, M., Tian, W., Zhuge, J., Zheng, X., Huang, T., Cai, D., . . . Fallon, J. T. (2014). Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. The American Journal of Surgical Pathology, 39(1), 127-131. doi:10.1097/PAS.0000000000000305

  • Zhong, M., Tian, W., Zhuge, J., Zheng, X., Huang, T., Cai, D., . . . Fallon, J. T. (2015). Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. The American Journal of Surgical Pathology, 39(1), 127-131. doi:10.1097/PAS.0000000000000305

  • Zhong, M., Vail, E., Huang, W., Mayogowda, P., Dimitrova, N., Fallon, J. T., & Zhong, M. (2016). Genomic mutational analysis of colorectal adenocarcinoma in patients under the age of 40. Journal of Molecular Diagnostics, 18(6), 1028.

  • Zhou, G., & Chu, S. (2013). Discovery of small molecule fusion inhibitors targeting HIV-1 gp41. Current Pharmaceutical Design, 19(10), 1818-1826.  doi:10.2174/1381612811319100006

  • Zhou, G., Liu, X., Su, D., Li, L., Xiao, M., & Wang, P. G. (2011). Large scale enzymatic synthesis of oligosaccharides and a novel purification process. Bioorganic & Medicinal Chemistry Letters, 21(1), 311-314.

  • Zhou, G., Sofiyev, V., Kaur, H., Snyder, B. A., Mankowski, M. K., Hogan, P. A., . . . Gochin, M. (2014). Structure-activity relationship studies of indole-based compounds as small molecule HIV-1 fusion inhibitors targeting glycoprotein 41. Journal of Medicinal Chemistry, 57(12), 5270–5281. doi:10.1021/jm500344y

  • Zhou, G., Wu, D., Hermel, E., Balogh, E., & Gochin, M. (2010). Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41. Bioorganic & Medicinal Chemistry Letters, 20(5), 1500-1503. This material can be found here.

  • Zhou, G., Wu, D., Snyder, B., Ptak, R. G., Kaur, H., & Gochin, M. (2011). Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 Glycoprotein-41. Journal of Medicinal Chemistry, 54(20), 7220–7231.

  • Zhou, J., Yang, Z., Tsuji, T., Gong, J., Xie, J., Chen, C., . . . Amar, S. (2011). LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene, 30(16), 1892-1900. doi:10.1038/onc.2010.575

  • Zhou, M., Wagner, L. M., Diflo, T., & Naegle, M. (2015). Implementation of the high-risk Alcoholism Relapse Scale in a liver transplant clinic. Gastroenterology Nursing, 38(6), 447-454. doi:10.1097/SGA.0000000000000168

  • Zhou, Q., & Amar, S. (2006). Identification of proteins differentially expressed in human monocytes exposed to porphyromonas gingivalis and its purified components by high-throughput immunoblotting. Infection and Immunity, 74(2), 1204-1214. doi:10.1128/IAI.74.2.1204-1214.2006

  • Zhou, Q., & Amar, S. (2007). Identification of signaling pathways in macrophage exposed to porphyromonas gingivalis or to its purified cell wall components. Journal of Immunology, 179(11), 7777-7790. This material can be found here.

  • Zhou, Q., Desta, T., Fenton, M., Graves, D. T., & Amar, S. (2005). Cytokine profiling of macrophages exposed to porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infection and Immunity, 73(2), 935-943. doi:10.1128/IAI.73.2.935-943.2005

  • Zhou, Q., Leeman, S. E., & Amar, S. (2009). Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses. Proceedings of the National Academy of Sciences of the United States of America, 106(26), 10740-10745. doi:10.1073/pnas.0904412106

  • Zhou, Q., Leeman, S. E., & Amar, S. (2011). Signaling mechanisms in the restoration of impaired immune function due to diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 108(7), 2867-2872. doi:10.1073/pnas.1019270108

  • Zhou, S., Wang, F., Hsieh, T. C., Wu, J. M., & Wu, E. (2013). Thalidomide: A notorious sedative to a wonder anticancer drug. Current Medicinal Chemistry, 20(33), 4102-4108. This material can be found here.

  • Zhou, S., Wang, F., Wong, E. T., Fonkem, E., Hsieh, T. C., Wu, J. M., & Wu, E. (2013). Salinomycin: A novel anti-cancer agent with known anti-coccidial activities. Current Medicinal Chemistry, 20(33), 4095-4101. This material can be found here.

  • Zhou, S., Wang, F., Xiang, S.H., Wong, E. T., Hsieh, T. C., . . . Wu, J. M. (2014). Identification of two salinomycin binding targets in neuroblastoma. Cancer Research, 74(19 Suppl.), 4614.

  • Zhou, S., Wang, F., Xiang, S., Wong, E., Hsieh, T. C., . . . Wu, J. M. (2014). Identification and clinical prognosis of salinomycin binding targets in neuroblastoma. FASEB Journal, 28(1 Suppl.), LB613.

  • Zhou, W., Blay, E.,Jr, Varu, V., Ali, S., Jin, M. Q., Sun, L., & Joh, J. H. (2014). Outcome and clinical significance of delayed endoleaks after endovascular aneurysm repair. Journal of Vascular Surgery, 59(4), 915-920. doi:10.1016/j.jvs.2013.10.093

First Prev 282 283 284 285 286 287 288 289 290 291 Next Last